CONTINUOUS INTRAVENOUS EPOPROSTENOL VERSUS CONVENTIONAL THERAPY IN PULMONARY-HYPERTENSION DUE TO THE SCLERODERMA SPECTRUM OF DISEASES - A 12-WEEK, MULTICENTER, RANDOMIZED, CONTROLLED TRIAL
Db. Badesch et al., CONTINUOUS INTRAVENOUS EPOPROSTENOL VERSUS CONVENTIONAL THERAPY IN PULMONARY-HYPERTENSION DUE TO THE SCLERODERMA SPECTRUM OF DISEASES - A 12-WEEK, MULTICENTER, RANDOMIZED, CONTROLLED TRIAL, Circulation, 98(17), 1998, pp. 3226-3226
Citations number
NO
Categorie Soggetti
Peripheal Vascular Diseas",Hematology,"Cardiac & Cardiovascular System